ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Is Betahistine Effective in the Treatment of Ménière’s Disease?

by Sean Holmes, MD, Anil K. Lalwani, MD, and Gauri Mankekar, MD, PhD • December 13, 2021

  • Tweet
  • Email
Print-Friendly Version

TRIO Best PracticeTRIO Best Practice articles are brief, structured reviews designed to provide the busy clinician with a handy outline and reference for day-to-day clinical decision making. The ENTtoday summaries below include the Background and Best Practice sections of the original article. To view the complete Laryngoscope articles free of charge, visit Laryngoscope.

You Might Also Like

No related posts.

Explore This Issue
December 2021

Background

Ménière’s disease (MD), or endolymphatic hydrops, is an idiopathic disorder commonly affecting adults between 40 and 60 years of age. Medical therapy is focused on treatment of acute episodes, prophylaxis, and mitigation of disease progression during the interval between attacks. Patients who receive no improvement after lifestyle changes are frequently treated with diuretic or betahistine or antihistamine therapies.

Betahistine, a partial H1 receptor agonist and potent H3 receptor antagonist, is widely used in Europe and the rest of the world in the treatment of MD; however, lacking FDA approval, it is unavailable in the United States. Betahistine is known to increase cochlear blood flow and is well tolerated at doses of 16 to 48 mg daily with no reported significant adverse events. It is contraindicated in patients with asthma, renal or cardiac disease, and allergies or hypersensitivities to the medication. In this Triological Society Best Practice, we review the current literature to determine whether betahistine is effective in the treatment of MD.

Best Practice

Though some studies show benefit, high-quality data demonstrating the efficacy of betahistine in the treatment of MD is absent. Despite mixed results, it remains popular due to a very low risk profile. Definitive large-scale randomized controlled trials with standardized diagnostic criteria, dosing regimens, and long-term follow-ups are required to assess the efficacy of betahistine in the treatement of MD. 

Filed Under: Otology/Neurotology, Otology/Neurotology, TRIO Best Practices Tagged With: Meniere's disease, treatmentIssue: December 2021

You Might Also Like:

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Neurogenic Cough Is Often a Diagnosis of Exclusion
    • What Happens to Medical Students Who Don’t Match?
    • Complications for When Physicians Change a Maiden Name
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • What Happens to Medical Students Who Don’t Match?
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Vertigo in the Elderly: What Does It Mean?
    • Neurogenic Cough Is Often a Diagnosis of Exclusion
    • Why We Get Colds
    • Are the Jobs in Healthcare Good Jobs?
    • What Really Works in Functional Rhinoplasty?
    • Is the Best Modality to Assess Vocal Fold Mobility in Children Flexible Fiberoptic Laryngoscopy or Ultrasound?
    • Three Primary Treatment Strategies Show No Differences in Swallow Outcome for Patients with Low- to Intermediate-Risk Tonsil Cancer

Polls

Do you have physician assistants in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2023 The Triological Society. All Rights Reserved.
ISSN 1559-4939